MX2014003408A - N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1). - Google Patents
N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1).Info
- Publication number
- MX2014003408A MX2014003408A MX2014003408A MX2014003408A MX2014003408A MX 2014003408 A MX2014003408 A MX 2014003408A MX 2014003408 A MX2014003408 A MX 2014003408A MX 2014003408 A MX2014003408 A MX 2014003408A MX 2014003408 A MX2014003408 A MX 2014003408A
- Authority
- MX
- Mexico
- Prior art keywords
- oxazin
- cyclopenta
- hexahydro
- difluoro
- amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invención proporciona N- (3- (2-amino-6, 6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta [e] [1,3] oxazin-4-il)-fenil)-amidas de la fórmula I (ver Fórmula) que tienen actividad inhibidora de la BACE1, su obtención, composiciones farmacéuticas que las contienen y su utilización como sustancias terapéuticamente activas. Los compuestos activos de la presente invención son útiles para el tratamiento terapéutico y/o profiláctico p.ej. de la enfermedad de Alzheimer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11182172 | 2011-09-21 | ||
PCT/EP2012/068287 WO2013041499A1 (en) | 2011-09-21 | 2012-09-18 | N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as bace1 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014003408A true MX2014003408A (es) | 2014-04-10 |
Family
ID=46852012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014003408A MX2014003408A (es) | 2011-09-21 | 2012-09-18 | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1). |
Country Status (11)
Country | Link |
---|---|
US (2) | US20130073953A1 (es) |
EP (1) | EP2758393A1 (es) |
JP (1) | JP2014526534A (es) |
KR (1) | KR20140069183A (es) |
CN (1) | CN103827110A (es) |
AR (1) | AR087915A1 (es) |
BR (1) | BR112014006763A2 (es) |
CA (1) | CA2844654A1 (es) |
MX (1) | MX2014003408A (es) |
RU (1) | RU2014113679A (es) |
WO (1) | WO2013041499A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009151098A1 (ja) | 2008-06-13 | 2009-12-17 | 塩野義製薬株式会社 | βセクレターゼ阻害作用を有する含硫黄複素環誘導体 |
AU2010328975B2 (en) | 2009-12-11 | 2015-01-22 | Shionogi & Co. Ltd. | Oxazine derivative |
KR20100075786A (ko) * | 2010-05-19 | 2010-07-05 | 세창인스트루먼트(주) | 웹사이트 영역취합시스템 및 그 방법 |
CN103631475A (zh) * | 2012-08-29 | 2014-03-12 | 腾讯科技(深圳)有限公司 | 切换窗口的方法和装置 |
US9540359B2 (en) | 2012-10-24 | 2017-01-10 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity |
CA2902212C (en) | 2013-03-01 | 2020-10-13 | Amgen Inc. | Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
AP2015008716A0 (en) | 2013-03-08 | 2015-09-30 | Amgen Inc | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
WO2015023703A1 (en) | 2013-08-12 | 2015-02-19 | Pharmacyclics, Inc. | Methods for the treatment of her2 amplified cancer |
TW201623295A (zh) | 2014-04-11 | 2016-07-01 | 塩野義製藥股份有限公司 | 具有bace1抑制活性之二氫噻及二氫衍生物 |
CN105278824B (zh) * | 2014-07-31 | 2018-06-26 | 维沃移动通信有限公司 | 一种终端设备的截屏方法及其终端设备 |
MX2017001794A (es) | 2014-08-08 | 2017-06-29 | Amgen Inc | Compuestos de tiazin-2-amina fusionados con ciclopropilo como inhibidores de beta-secretasa y metodos de uso. |
MX2017012188A (es) | 2015-03-20 | 2017-12-15 | Hoffmann La Roche | Inhibidores de beta-secretasa 1 (bace1). |
WO2019208693A1 (en) | 2018-04-27 | 2019-10-31 | Shionogi & Co., Ltd. | Tetrahydropyranooxazine derivatives having selective bace1 inhibitory activity |
CN110109593B (zh) * | 2019-04-29 | 2021-04-02 | 维沃移动通信有限公司 | 一种截屏方法及终端设备 |
TWI810101B (zh) * | 2022-10-27 | 2023-07-21 | 南亞塑膠工業股份有限公司 | 碟鏈系統 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3395145A (en) * | 1966-08-17 | 1968-07-30 | Warner Lambert Pharmaceutical | 2-aryl-1-oxa-3-azaspiro [5, 5] undec-2-enes |
US20080092077A1 (en) * | 2006-09-14 | 2008-04-17 | Cqgt, Llc | Interactive streaming news headline display |
CN102186841A (zh) * | 2008-10-22 | 2011-09-14 | 盐野义制药株式会社 | 具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物 |
WO2011071057A1 (ja) * | 2009-12-09 | 2011-06-16 | 塩野義製薬株式会社 | 含硫黄複素環誘導体を含有するアルツハイマー症の治療用または予防用医薬組成物 |
US7964594B1 (en) * | 2009-12-10 | 2011-06-21 | Hoffmann-La Roche Inc. | Amino oxazine derivatives |
AU2010328975B2 (en) * | 2009-12-11 | 2015-01-22 | Shionogi & Co. Ltd. | Oxazine derivative |
UA103272C2 (uk) | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
-
2012
- 2012-09-11 US US13/609,303 patent/US20130073953A1/en not_active Abandoned
- 2012-09-11 US US13/609,304 patent/US8476264B2/en not_active Expired - Fee Related
- 2012-09-18 RU RU2014113679/04A patent/RU2014113679A/ru not_active Application Discontinuation
- 2012-09-18 BR BR112014006763A patent/BR112014006763A2/pt not_active IP Right Cessation
- 2012-09-18 CA CA2844654A patent/CA2844654A1/en not_active Abandoned
- 2012-09-18 KR KR1020147010348A patent/KR20140069183A/ko not_active Application Discontinuation
- 2012-09-18 JP JP2014531193A patent/JP2014526534A/ja active Pending
- 2012-09-18 WO PCT/EP2012/068287 patent/WO2013041499A1/en active Application Filing
- 2012-09-18 MX MX2014003408A patent/MX2014003408A/es unknown
- 2012-09-18 EP EP12759458.8A patent/EP2758393A1/en not_active Withdrawn
- 2012-09-18 CN CN201280046301.7A patent/CN103827110A/zh active Pending
- 2012-09-19 AR ARP120103443A patent/AR087915A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2758393A1 (en) | 2014-07-30 |
US8476264B2 (en) | 2013-07-02 |
RU2014113679A (ru) | 2015-10-27 |
CN103827110A (zh) | 2014-05-28 |
KR20140069183A (ko) | 2014-06-09 |
AR087915A1 (es) | 2014-04-23 |
US20130073953A1 (en) | 2013-03-21 |
CA2844654A1 (en) | 2013-03-28 |
JP2014526534A (ja) | 2014-10-06 |
WO2013041499A1 (en) | 2013-03-28 |
BR112014006763A2 (pt) | 2017-03-28 |
US20130072478A1 (en) | 2013-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014003408A (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1). | |
MX2013013692A (es) | Halogenoalquil-1,3-oxazinas como inhibidores de beta secretasa 1 (bace1) y/o beta secretasa 2 (bace2). | |
MX2013008213A (es) | N-[3-(5-amino-3,3a,7,7a-tetrahidro-1h-2,4-dioxa-6-aza-inden-7-il) -fenil]-amidas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
MX2013007558A (es) | 1,4-oxazinas como inhibidores de los genes enzima de segmentacion de la proteina precursora del sitio 1 y/o 2 (bace1 y/o bace2). | |
MX2013010795A (es) | 1,3 oxazinas como inhibidores de beta-secretasa 1 (bace 1) y/o la beta-secretasa 2 (beta 2). | |
MX2013007957A (es) | 1,4-oxazinas como inhibidores de los genes de enzima de segmentacion de la proteina precursora amiloide del sitio beta 1 y/o (bace1 y/o bace2). | |
EA201391670A1 (ru) | 1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
UA103272C2 (uk) | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 | |
EA201391752A1 (ru) | Спиро-[1,3]-оксазины и спиро-[1,4]-оксазепины в качестве ингибиторов bace1 и/или bace2 | |
MX2013008478A (es) | 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2). | |
MX2015008957A (es) | Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1). | |
IN2012DN00766A (es) | ||
MX2013014007A (es) | [1,3] oxazinas. | |
MX2013014194A (es) | 1,3-tiazepinas fusionadas a ciclopropilo como inhibidores de beta-secretasa 1 (bace) y/o beta-secretasa 2 (bace 2). | |
PH12014501334A1 (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | |
PH12015502365B1 (en) | Bace1 inhibitors | |
MX336774B (es) | Moduladores alostericos positivos de receptores m1 de la quinolina amida. | |
PH12014502623B1 (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
PH12014502541A1 (en) | 5-amino [1,4] thiazines as bace 1 inhibitors | |
PH12017501668A1 (en) | Bace1 inhibitors | |
MX2013002398A (es) | Inhibidores de beta-secretasa (base) para su uso en tratamiento de diabetes. | |
MX365292B (es) | 5-aril-1-imino-1-oxo-[1,2,4]tiadiazinas. | |
MX2016016061A (es) | 2,2,2-trifluoroetil-tiadiazinas. |